Hitherto, reports on AGP glycosylation mainly highlighted alterations in branching and (antennary) fucosylation to be associated with (liver) diseases [40, 41], and more recently sialylation in NASH and HCC [12]. This evidence concerns the gene ATP5MK and hepatocellular carcinoma.